(Q36136508)

12 August 2017

Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance (English)

1 reference

12 August 2017

L Kaklamanis

1

1 reference

12 August 2017

M I Koukourakis

2

1 reference

12 August 2017

R Leek

3

1 reference

12 August 2017

A Giatromanolaki

4

1 reference

12 August 2017

M Ritter

5

1 reference

12 August 2017

R Whitehouse

6

1 reference

12 August 2017

K C Gatter

7

1 reference

12 August 2017

A L Harris

8

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 November 1996

1 reference

British Journal of Cancer

12 August 2017

1 reference

12 August 2017

74

1 reference

12 August 2017

10

1 reference

12 August 2017

1627-1631

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1996.599

12 August 2017

0 references

cites work

Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin 4 receptor (CD 124)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

A wide range of human cancers express interleukin 4 (IL4) receptors that can be targeted with chimeric toxin composed of IL4 and Pseudomonas exotoxin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

Structure of the IL4 receptor and signal transduction mechanism of IL4.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

Identification of a T cell-derived b cell growth factor distinct from interleukin 2.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

Elevated expression of the interleukin 4 receptor in carcinoma: a target for immunotherapy?

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

Human tumour-associated NK cells secrete increased amounts of interferon-gamma and interleukin-4

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

Quantitative assays of epidermal growth factor receptor in human breast cancer: cut-off points of clinical relevance.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

Murine interleukin-4 displays potent anti-tumor activity in vivo

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

Analysis of the fine distribution of thymic epithelial microenvironmental molecules by immuno-electron microscopy

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

Tumour-associated upregulation of the IL-4 receptor complex.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

Interleukin 4 alone and with gamma-interferon or alpha-tumor necrosis factor inhibits cell growth and modulates cell surface antigens on human renal cell carcinomas

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

Interleukin 4 potentiates the antiproliferative effects of tumor necrosis factor on various tumor cell lines

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2074844

Functional evidence for a monoclonal antibody that binds to the human IL-4 receptor

23 September 2018

1 reference

12 December 2020

Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)

1 reference

12 December 2020

The human thymus microenvironment: heterogeneity detected by monoclonal anti-epithelial cell antibodies

1 reference

12 December 2020

Lymphokine regulation of inflammatory processes: interleukin-4 stimulates fibroblast proliferation

1 reference

12 December 2020

IL-4 regulates endothelial cell activation by IL-1, tumor necrosis factor, or IFN-gamma

1 reference

12 December 2020

Interleukin 4 receptor expression on human lung tumors and normal lung

1 reference

12 December 2020

Interleukin-4 is a potent mitogen for capillary endothelium

1 reference

12 December 2020

Expression of high-affinity interleukin 4 receptors on murine sarcoma cells and receptor-mediated cytotoxicity of tumor cells to chimeric protein between interleukin 4 and Pseudomonas exotoxin

1 reference

12 December 2020

Inhibition of colon and breast carcinoma cell growth by interleukin-4

1 reference

12 December 2020

Induction of tumor immunity by cytokine cDNA transfected Lewis lung carcinoma

1 reference

12 December 2020

IL-2 inhibits the induction of systemic antitumour immunity by IL-4 in the peritumoural treatment of experimental melanoma

1 reference

12 December 2020

A computer model of the interleukin-4/receptor complex

1 reference

12 December 2020

Expression of high-affinity IL-4 receptors on human melanoma, ovarian and breast carcinoma cells

1 reference

12 December 2020

Inhibition of alloreactivity by mAb MR6: differential effects on IL-2- and IL-4-producing human T cells

1 reference

12 December 2020

Loss of transporter in antigen processing 1 transport protein and major histocompatibility complex class I molecules in metastatic versus primary breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1996.599

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

8932345

1 reference